U.S. Marine and Shipping Stock News

UBS recently named Cigna Group as a top healthcare pick, arguing that concerns around pharmacy benefit manager reform have largely been absorbed and that the company’s move to a rebate-free model has improved earnings visibility. The analysts also highlighted Cigna’s limited exposure to government reimbursement, its discount relative to peers, and the potential for share buybacks as key supports for the investment case. We’ll now examine how UBS’s view of Cigna as undervalued with improved...

Plains GP Holdings filed a new shelf registration for its Class A common shares. The filing gives the company flexibility to issue new equity securities in the future. The move is a material corporate action that can affect funding plans and existing shareholders. Plains GP Holdings (NasdaqGS:PAGP) last closed at $24.42, with the shares showing returns of 2.8% over the past week and 8.3% over the past month. Over longer periods, the stock has returns of 25.8% year to date and 24.1% over the...

Damora Therapeutics recently overhauled its leadership, appointing former Arcus Biosciences executive Jennifer Jarrett as President and Chief Executive Officer and adding industry veterans Cameron Turtle and Mike Landsittel to its Board, while several directors resigned. This reshaping of the executive team brings together extensive biopharma operating, deal-making and capital markets experience, potentially influencing how Damora pursues future partnerships, financing and commercialization...

Cimpress (CMPR) has put a new capital return plan in focus, announcing a share repurchase program of up to US$200 million shortly after its previous buyback expired and its removal from the NASDAQ Internet Index. See our latest analysis for Cimpress. At a share price of US$72.75, Cimpress has delivered a 90 day share price return of 9.25% and a 1 year total shareholder return of 59.05%. The new US$200 million buyback plan keeps capital allocation in focus after its removal from the NASDAQ...

Investors may be wondering if Akamai Technologies at around US$110 a share still offers value, or if most of the easy gains are already on the table. The stock closed at US$110.22, with a 3.7% decline over the last 7 days, a 12.0% gain over 30 days, 29.5% year to date, 36.9% over 1 year, 41.5% over 3 years, and 6.1% over 5 years. This gives you a wide range of recent return experiences to weigh up. Recent coverage has focused on Akamai's role as a key infrastructure player for content...

Recent share performance and business snapshot Occidental Petroleum (OXY) has drawn investor attention after a recent share price move, with the stock last closing at $66.24, set against a value score of 2 and an intrinsic discount estimate of 42.71%. See our latest analysis for Occidental Petroleum. The recent 1-month share price return of 24.79% and 90-day share price return of 59.77% point to strong positive momentum. The 1-year total shareholder return of 37.10% and 5-year total...

Over the last 7 days, the United States market has dropped 3.5%, yet it has seen a rise of 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these growth opportunities.

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year with anticipated earnings growth of 15% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading below their estimated worth can provide opportunities for investors seeking value amidst broader market trends.

If you are wondering whether AT&T's current price really reflects what you are getting as a shareholder, you are asking the right question. AT&T recently closed at US$28.78, with returns of 0.1% over 7 days, 2.7% over 30 days, 17.2% year to date and 6.2% over the last year. This gives you a useful starting point for judging value. Recent coverage around AT&T has focused on its role as a major U.S. telecom provider and how it fits into long term connectivity trends. This context helps frame...

S&P Global has appointed Firdaus Bhathena as Executive Vice President and Chief Technology and Transformation Officer, while also facing shareholder proposals on special meeting rights and charitable giving oversight ahead of its May 20, 2026 annual meeting. This combination of a senior technology hire and active governance-focused shareholders highlights how digital transformation and investor scrutiny are shaping S&P Global’s next phase. We’ll now examine how Bhathena’s technology and...

Over the last 7 days, the United States market has experienced a 3.5% decline, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may offer resilience amid market fluctuations.

Progressive (NYSE:PGR) has completed two major fixed income offerings totaling more than $1.4b in senior unsecured notes. The new notes mature in 2031 and 2036, adding longer dated debt to the company’s capital structure. AM Best assigned an 'a' (Excellent) credit rating and a stable outlook to these new unsecured notes. Progressive, trading at $201.39, comes into this debt issuance with a mixed share price record, including a 24.2% decline over the past year and gains of 51.9% over three...

Philip Morris International (NYSE:PM) has released its Value Report 2025, outlining updated priorities across its smoke free transition. The company has also introduced its Value Plan 2030+, setting new long term focus areas for consumer health impact, climate, biodiversity, and workforce well being. These disclosures expand on prior transformation efforts by linking sustainability goals with business planning and capital allocation over the coming years. For investors following NYSE:PM,...

Over the last 7 days, the United States market has dropped 3.5%, but it has seen a rise of 14% over the past year, with earnings projected to grow by 15% annually in coming years. In light of these conditions, identifying stocks with strong financial health and growth potential is crucial for investors seeking opportunities beyond mainstream options. Penny stocks, though an outdated term, still represent a niche investment area that can offer surprising value and potential returns when backed...

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can be a rewarding strategy for investors seeking potential opportunities.

Over the last 7 days, the United States market has experienced a 3.5% drop, although it has shown resilience with a 14% rise over the past year and an earnings growth forecast of 15% annually. In this context, dividend stocks that offer consistent payouts and potential for long-term appreciation can be attractive options for investors seeking stability amidst fluctuating market conditions.

What Trump Media & Technology Group’s recent trading performance signals for investors With no single headline event driving attention, Trump Media & Technology Group (DJT) has been drawing interest mainly because of its trading performance, including a 1 day gain of 2.95% and a month decline of 18.58%. See our latest analysis for Trump Media & Technology Group. That recent 1 day 2.95% share price gain sits against a weaker backdrop, with the 30 day share price return of 18.58% and year to...

Wondering if Builders FirstSource at around US$78.85 is starting to look attractive again, or if the market is still pricing in too much optimism. The stock is down around 6.9% over the past week, 24.4% over the past month, and 24.6% year to date, with a 36.9% decline over the last year and a 65.7% gain over five years. Recent headlines have focused on Builders FirstSource within broader discussions about U.S. construction activity, housing demand, and building products suppliers. This helps...

Steel Dynamics (NasdaqGS:STLD) announced that long serving directors Richard P. Teets, Jr. and Gabriel L. Shaheen plan to retire from its board at the upcoming annual meeting. The changes will reduce long term board presence and open seats for new directors once shareholders vote at the meeting. Both directors have served during key phases of the company’s development in the steel and metals recycling sector. For you as an investor, this matters because board composition shapes how Steel...

Elastic Cloud Hosted has received FedRAMP High authorization on AWS GovCloud (US), allowing use by U.S. federal agencies for highly sensitive workloads. This approval places Elastic directly into one of the most security focused cloud segments within the government and defense market. The development extends Elastic's existing government presence at a time when the NYSE:ESTC share price stands at $49.41. For investors tracking NYSE:ESTC, the FedRAMP High authorization ties a clear...

Corcept Therapeutics (CORT) has received U.S. Food and Drug Administration approval for Lifyorli, to be used with nab paclitaxel in adults with platinum resistant ovarian, fallopian tube, or primary peritoneal cancer. See our latest analysis for Corcept Therapeutics. Corcept’s latest FDA approval lands after a volatile stretch, with a 12.71% 7 day share price return and a 6.78% 30 day share price return, alongside a 1 year total shareholder return of 58.53% decline. Meanwhile, 3 and 5 year...

New independent cost impact model evaluates Indivior's extended-release buprenorphine (SUBLOCADE) in U.S. correctional facilities. The model suggests SUBLOCADE, a monthly injectable for opioid use disorder, may meaningfully cut staff time and related costs versus other treatments. Findings, published in a peer reviewed journal, highlight potential operational benefits and treatment access gains for jails and prisons. For investors watching Indivior Pharmaceuticals (NasdaqGS:INDV), this...

Wondering whether CubeSmart's current share price still offers value, or if most of the opportunity has already been priced in? This article breaks down what the numbers actually say about the stock. CUBE has had a mixed run recently, with a 3.4% decline over 7 days, a 12.7% decline over 30 days, a 1.4% gain year to date, and an 11.4% decline over the last year, which can change how the market views its risk and return profile. Recent coverage has focused on CubeSmart's share price moves and...

DTE Energy (DTE) drew fresh attention after its recent trading session, with the stock closing at $146.06 and short term returns showing mixed moves over the past week, month and past 3 months. See our latest analysis for DTE Energy. Looking beyond the latest move, DTE Energy’s share price return of 12.0% year to date and 12.5% over 90 days points to building momentum. The 1 year total shareholder return of 9.2% and 3 year total shareholder return of 48.6% reflect a solid longer term outcome...